These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9735486)

  • 21. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future developments in sublingual immunotherapy.
    Didier A
    Allergy; 2006; 61 Suppl 81():29-31. PubMed ID: 16792604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of immunotherapy in treatment of IgE-induced allergic diseases].
    Müller UR
    Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of six years allergen immunotherapy in allergic rhinitis and allergic asthma.
    Farid R; Ghasemi R; Baradaran-Rahimi M; Jabbari F; Ghaffari J; Rafatpanah H
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):29-31. PubMed ID: 17242501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific immunotherapy in pollen allergy.
    Wallner M; Briza P; Thalhamer J; Ferreira F
    Curr Opin Mol Ther; 2007 Apr; 9(2):160-7. PubMed ID: 17458170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
    Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyposensitization in allergic rhinitis. Immunotherapy. Indications and contra-indications.
    Wihl JA
    Acta Otolaryngol Suppl; 1979; 360():19-21. PubMed ID: 287338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Position paper on allergen immunotherapy. Report of a BSACI working party. January-October 1992.
    Clin Exp Allergy; 1993 Aug; 23 Suppl 3():1-44. PubMed ID: 8258111
    [No Abstract]   [Full Text] [Related]  

  • 37. Sublingual immunotherapy: where do we stand? Present and future.
    Passalacqua G; Pawankar R; Baena-Cagnani CE; Canonica GW
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):1-3. PubMed ID: 19106697
    [No Abstract]   [Full Text] [Related]  

  • 38. Allergy immunotherapy for primary care physicians.
    Stokes JR; Casale TB
    Am J Med; 2006 Oct; 119(10):820-3. PubMed ID: 17000208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compliance with allergen immunotherapy.
    Lower T; Henry J; Mandik L; Janosky J; Friday GA
    Ann Allergy; 1993 Jun; 70(6):480-2. PubMed ID: 8507043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.